Details of the Drug

General Information of Drug (ID: DMAITRL)

Drug Name

MKC-1313

Synonyms

HDAC inhibitors, EntreMed; HDAC inhibitors, Miikana; Histone deacetylase inhibitors (cancer); MKC-1192; MKC-1704; HDAC inhibitor (cancer), EntreMed; Histone deacetylase inhibitors (cancer), EntreMed; Histone deacetylase inhibitors (cancer), Miikana

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Terminated	[1]
------------------------------------------------------------------------------------

Structure

3D Structure is Not Available

3D MOL

2D MOL

Cross-matching ID

TTD ID: D0RO0T

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Histone deacetylase (HDAC)	TTBH0VX	NOUNIPROTAC	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024821)
2	ENTREMED TO ACQUIRE MIIKANA THERAPEUTICS. U.S. Securities and Exchange Commission. December 22, 2005.